Neoadjuvant Therapy is Associated with a Reduced Lymph Node Ratio in Patients with Potentially Resectable Pancreatic Cancer

BACKGROUND: The use of neoadjuvant therapy (NAC) for the treatment of potentially resectable pancreatic cancer remains controversial. In this study we sought to evaluate cancer-specific end-points in patients undergoing a NAC vs. a surgery-first (SF) approach with specific emphasis on lymph node met...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Ann Surg Oncol
Main Authors: Roland, Christina L., Yang, Anthony D., Katz, Matthew H. G., Chatterjee, Deyali, Wang, Huamin, Lin, Heather, Vauthey, Jean N., Pisters, Peter W., Varadhachary, Gauri R., Wolff, Robert A., Crane, Christopher H., Lee, Jeffrey E., Fleming, Jason B.
Format: Artigo
Jezik:Inglês
Izdano: 2014
Teme:
Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC5131370/
https://ncbi.nlm.nih.gov/pubmed/25352267
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1245/s10434-014-4192-6
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki